JCT  Vol.6 No.12 , November 2015
Treatment of Non Melanoma Skin Cancers: An Intra-Comparison Study of CuradermBEC5 and Various Established Modalities
Abstract: Dermatologists, surgeons, oncologists and radiotherapists usually jointly manage skin cancers. The strengths and limitations of the established procedures are known. A new naturally derived topical cream, CuradermBEC5, for the treatment of non melanoma skin cancers has previously been described. In this communication, intra-comparison treatments of skin cancer between CuradermBEC5 therapy and the established treatments, surgery, radiation therapy, laser therapy, photodynamic therapy, imiquimod cream and cryosurgery are presented. Non melanoma skin cancer cases that had previously been treated unsuccessfully with the established procedures were subsequently treated successfully with CuradermBEC5. These observations are interesting because the identical lesions were treated by various modalities. In addition to the superior efficacious outcome of CuradermBEC5 therapy versus the established treatments, the cosmetic end results with CuradermBEC5 treatment are remarkable.
Cite this paper: Cham, K. , Cham, A. , Chase, T. , Zhou, V. and Cham, B. (2015) Treatment of Non Melanoma Skin Cancers: An Intra-Comparison Study of CuradermBEC5 and Various Established Modalities. Journal of Cancer Therapy, 6, 1045-1053. doi: 10.4236/jct.2015.612114.

[1]   Cham, A., Cham, K., Chase T. and Cham, B.E. (2015) A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation CuradermBEC5. Journal of Cancer Treatment and Research, 3, 22-27.

[2]   Fighting the High Cost of RX Drugs.

[3]   Inside Daraprim’s Price Hike.

[4]   Daunter, B. and Cham, B.E. (1990) Solasodine Glycosides. In Vitro Preferential Cytotoxicity for Human Cancer Cells. Cancer Letters, 55, 209-220.

[5]   Lipscombe, R.J., Carter, S.J. and Ruane, M. (2005) Rhamnose Binding Protein. US Patent No. 6930171.

[6]   Cham, B.E. (2007) Solasodine Rhamnosyl Glycosides Specifically Bind Cancer Cell Receptors and Induce Apoptosis and Necrosis. Treatment for Skin Cancer and Hope for Internal Cancers. Res. J. Biol. Sci., 2, 503-514.

[7]   Sun, L., Zhao, Y., Li, X., Yuan, H., Cheng, A. and Lou, H. (2010) A Lysosomal-Mitochondrial Death Pathway Is Induced by Solamargine in Human K562 Leukemia Cells. Toxicology in Vitro, 24, 1504-1511.

[8]   Surgery for Basal Cell and Squamous Cell Skin Cancers. American Cancer Society.

[9]   Radiation therapy for Non melanoma Skin Cancer—WebMD.

[10]   Lasers in Cancer Treatment—National Cancer Institute.

[11]   Photodynamic Therapy for Skin Cancer. Accessed July 2015.

[12]   Imiquimod Topical: Medline plus Drug Information. Accessed September 2015.

[13]   Cryosurgery. Accessed September 2015.

[14]   Cham, B.E. (2013) Inspired by Nature, Proven by Science. The New Generation Cancer Treatment That Causes Cancer Cells to Commit Suicide. 1st Edition, Colorite Grahics Printers, Efate.

[15]   Cham, B.E. (1994) Solasodine Glycosides as Anti-Cancer Agents: Pre-Clinical and Clinical Studies. Asia Pacific Journal of Pharmacology, 9, 113-118.

[16]   Cham, B.E., Daunter, B. and Evans, R. (1991) Topical Treatment of Malignant and Premalignant Skin Cancers by Very Low Concentrations of a Standard Mixture (BEC) of Solasodine Glycosides. Cancer Letters, 59, 183-192.

[17]   Cham, B.E. (2011) Topical Solasodine Rhamnosyl Glycosides Derived from the Eggplant Treats Large Skin Cancers: Two Case Reports. International Journal of Clinical Medicine, 2, 473-477.

[18]   Cham, B.E. (2008) Cancer Intralesion Chemotherapy with Solasodine Rhamnosyl Glycosides. Research Journal of Biological Sciences, 3, 1008-1017.

[19]   Cham, B.E. and Meares, H.M. (1987) Glycoalkaloids from Solanum sodomaeum L. Are Effective in the Treatment of Skin Cancers in Man. Cancer Letters, 36, 111-118.

[20]   Punjabi, S., Cook, L.J., Kersey, P., Marks, R. and Cerio, R. (2008) Solasodine Glycoalkaloids: A Novel Topical Therapy for Basal Cell Carcinoma. A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicentre Study. International Journal of Dermatology, 47, 78-82.

[21]   Goldberg, L.H., Landau, J.M., Moody, M.N. and Vergilis-Kalner, I.J. (2011) Treatment of Bowen’s Disease on the Penis with Low Concentration of a Standard Mixture of Solasodine Glycosides and Liquid Nitrogen. Dermatologic Surgery, 37, 858-861.

[22]   Chase, T.R. (2011) CuradermBEC5 for Skin Cancers, Is It? An Overview. Journal of Cancer Therapy, 2, 728-745.

[23]   Cham, B.E. and Chase T.R. (2012) Solasodine Rhamnosyl Glycosides Cause Apoptosis in Cancer Cells, Do They Also Prime the Immune System Resulting in Long Term Protection? Planta Medica, 78, 349-353.

[24]   Cham, B.E. (2012) Intralesion and CuradermBEC5 Topical Combination Therapies of Solasodine Rhamnosyl Glycosides Derived from the Eggplant or Devil’s Apple Result in Rapid Removal of Large Skin Cancers. Methods of Treatment Compared. International Journal of Clinical Medicine, 3, 115-124.

[25]   Cham, B.E. (2013) Topical CuradermBEC5 Therapy for Periocular Nonmelanoma Skin Cancer: A Review of Clinical Outcomes. International Journal of Clinical Medicine, 4, 233-238.

[26]   Cham, B.E. (2013) Solasodine Glycosides: A Topical Therapy for Actinic Keratosis. A Single-Blind, Randomized, Placebo-Controlled, Parallel Group Study with CuradermBEC5. Journal of Cancer Therapy, 4, 588-596.

[27]   Cham, B.E. (2013) Drug Therapy: Solamargine and Other Solasodine Rhamnosyl Glycosides as Anticancer Agents. Modern Chemotherapy, 2, 33-49.

[28]   Cham, B.E. (2014) A Review of Solasodine Rhamnosides Therapy for in Situ Squamous Cell Carcinoma on the Penis. British Journal of Medicine and Medical Research, 4, 621-631.

[29]   Cham, A. and Cham, B.E. (2015) Treatment of Skin Cancer with a Selective Apoptotic-Inducing CuradermBEC5 Topical Cream Containing Solasodine Rhamnosides. International Journal of Clinical Medicine, 6, 326-333.